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Abstract
Background: Heart rate (HR) detection in premature infants 
using electrocardiography (ECG) is challenging due to a low 
signal amplitude and the fragility of the premature skin. Re-
cently, the dynamic light scattering (DLS) technique has 
been miniaturized, allowing noninvasive HR measurements 
with a single sensor. Objective: The aim was to determine 
the accuracy of DLS for HR measurement in infants, com-
pared to ECG-derived HR. Methods: Stable infants with a 
gestational age of ≥26 weeks, monitored with ECG, were el-
igible for inclusion. HR was measured with the DLS sensor at 
5 different sites for 15 min each. We recorded every 10th sec-
ond of the DLS-derived HR and the DLS signal-to-noise ratio 
(SNR), and the ECG-derived HR was extracted for analysis. 
Patients were randomly divided into 2 groups. In the first 
group, the optimal SNR cut-off value was determined and 
then applied to the second group to assess agreement. Re-
sults: HR measurements from 31 infants were analyzed. ECG-
DLS paired data points were collected at the forehead, an 
upper extremity, the thorax, a lower extremity, and the ab-
domen. When applying the international accuracy standard 
for HR detection, DLS accuracy in the first group (n = 15) was 
optimal at the forehead (SNR cut-off 1.66). Application of this 
cut-off to the second group (n = 16) showed good agree-
ment between DLS-derived HR and ECG-derived HR (bias 
–0.73 bpm; 95% limits of agreement –15.46 and 14.00 bpm) 
at the forehead with approximately 80% (i.e., 1,066/1,310) of 
all data pairs remaining. Conclusion: The investigated DLS 
sensor was sensitive to movement, overall providing less ac-
curate HR measurements than ECG and pulse oximetry. In 
this study population, specific measurement sites provided 
excellent signal quality and good agreement with ECG-de-
rived HR. © 2020 The Author(s)
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Premature infants are known to experience frequent 
episodes of bradycardia and apnea [1]. Drops in heart rate 
(HR) cause a potentially harmful decrease in cardiac out-
put and related hypoxia, requiring timely intervention 
[2]. To prevent serious complications, adequate and ac-
curate monitoring is mandatory. In infants, HR is closely 
correlated to cardiac output because their physiology per-
mits only limited stroke volume variation [3], emphasiz-
ing the importance of neonatal HR monitoring.
Electrocardiography (ECG), the current gold stan-
dard, and pulse oximetry are widely used for noninvasive 
HR monitoring in the neonatal intensive care unit 
(NICU). However, both technologies have their limita-
tions. Movement and the small size of the infant, togeth-
er with a low or small signal amplitude, electrical interfer-
ence, and the need for limiting the number of adhesives 
applied to the infant to prevent skin lesions [4–9], offer 
opportunities for new technologies [10].
Recently, a new miniaturized sensor has been devel-
oped, allowing noninvasive monitoring of hemodynamic 
parameters through dynamic light scattering (DLS). He-
moglobin motion is detected with a laser diode which 
emits a narrow light beam. Light scatters off moving hemo-
globin, creating a time-varying speckle pattern. The speck-
le pattern is analyzed in real time and provides information 
about, for example, the speed and size of hemoglobin par-
ticles, and translates this to a pulsatile flow waveform. This 
enables the DLS technique to measure multiple hemody-
namic parameters such as HR and, potentially, blood flow. 
The DLS HR is calculated from the spectrum analysis of 
the velocity wave. In previous studies, various DLS param-
eters were evaluated in animals and adult patients [11–14]. 
This is the first study to evaluate the potential of HR detec-
tion with DLS. As the signal quality of the DLS technique 
depends entirely on hemoglobin motion, the pulsatile sig-
nal is high even in small premature infants. Furthermore, 
DLS is an optical measurement technique, minimizing the 
effects of electrical interference. This study aimed to assess 
the potential of DLS for HR detection in infants, by evalu-
ating the signal quality of the DLS measurements and de-
termining agreement with ECG.
Materials and Methods
Study Setup
This prospective observational cohort study was conducted at 
a level III NICU at Erasmus MC - Sophia Children’s Hospital, Rot-
terdam, The Netherlands.
Study Population
Stable infants with a gestational age (GA) of ≥26 weeks, moni-
tored with ECG and pulse oximetry in the NICU, were eligible for 
inclusion. Infants with skin disorders, for which the double-sided 
skin adhesives used (LEA Medizintechnik GmbH, Giessen, Germa-
ny) were contraindicated, were excluded. A stable condition was de-
fined as the absence of sepsis, fever, severe desaturation, severe ap-
nea, or severe incidents during nursing and feeding. Patients’ char-
acteristics at birth and during the measurement period were 
documented. Patients were randomly divided into 2 groups. In the 
first group, the optimal cut-off for signal quality was calculated based 
on the norm for accuracy of HR detection. This cut-off was applied 
to the second group to compare agreement of DLS with ECG.
Equipment
Dynamic Light Scattering
Hemodynamic parameters were measured with an mDLSTM 
sensor (Elfi-Tech Ltd., Rehovot, Israel) which was connected to a 
computer for data collection and real-time display. The sensor 
contains a class I, continuous wave, vertical-cavity-surface-emit-
ting laser (VCSEL, wavelength 852.4 ± 2 nm, and peak energy 0.85 
mW) and an optoelectronic detection system (Fig. 1a). No real-
time (interbeat) analysis or averaging was applied. HR was mea-
sured at 5 different sites with the mDLSTM sensor, for 15 min each. 
Measurements were performed at the forehead, upper and lower 
extremities, thorax, and abdomen, in a random order. The mea-
sured signal-to-noise ratio (SNR) parameter indicated the signal 
quality. A Biliband® (Natus Medical Inc., San Carlos, CA, USA) 
was used to protect the neonatal retina from laser exposure.
ECG and Pulse Oximetry
As part of standard care monitoring, ECG (Dräger M540, 
Dräger Medical GmbH, Lübeck, Germany) and pulse oximetry 
(Masimo SET Radical pulse oximeter, Masimo Corp., Irvine, CA, 
USA; POX-S) were available, with an averaging interval of 10 and 
12 s, respectively. An additional pulse oximeter (Masimo SET Rad-
ical-7; POX-A) was attached to the infant during the measurement 
period and acquired HR data with an averaging interval of 2 s at 
normal sensitivity. Based on the location of the POX-S, the POX-A 
was placed such that both an upper and lower extremity were pro-
vided with pulse oximetry for assessing the pulsatile signal.
Data Logging
Vital parameters monitored as standard of care, as well as all 
data from all study devices, were logged at a rate of 1 Hz. The 
logged parameters included ECG-derived HR, pulse oximetry pa-
rameters, DLS-derived HR, and DLS SNR.
Devices and Software
Measurements were performed using the mDLSTM sensor, soft-
ware v3.81, and the data collection system PC GUI v1.0.9.5 (Elfi-
Tech Ltd., Rehovot, Israel). The Dräger Infinity M540 monitor had 
software vVG3.
Statistical Analyses
Patient characteristics are presented as median (interquartile 
range [IQR]) or n (%). Significance of differences between the 2 
groups was tested with the Mann-Whitney U test for continuous 
data and Fisher’s exact test for categorical variables. Results were 
considered significant with a two-sided p value < 0.05.




The first minute of measurement was excluded because of sen-
sor stabilization time and potential initial unrest of the infant. In 
order to adjust for the time-averaged ECG data, only every 10th 
second of the DLS-derived HR, the DLS SNR, and the pulse oxim-
etry parameters was included for analysis.
In the first group, accuracy of HR measured with the mDLSTM 
sensor was evaluated for compliance to the IEC 60601-2-27: 2011 
standard [15], with the ECG value as a reference. The percentage 
deviation of DLS relative to the ECG reference value was calculated 
and the measurement was classified as accurate or inaccurate based 
on the norm criteria for accuracy. The sensitivity and specificity of 
the SNR for selecting norm-compliant DLS HR measurements 
were determined with an area under the receiver operating charac-
teristic (ROC) curve according to the method of Obuchowski [16], 
adjusting for clustered data. The optimal SNR at each measurement 
location was calculated with Youden’s Index (J) [17]. To visualize 
the effect of the signal quality or SNR on agreement between DLS 
and ECG, Bland-Altman analysis of agreement, corrected for re-
peated measurements, was performed [18]. Agreement was as-
sessed by calculating the mean difference (bias) between DLS-de-
rived HR and ECG-derived HR, with ±1.96 SD around the mean 
difference as upper and lower limits of agreement (LoA). Bias, up-
per LoA, and lower LoA were calculated and plotted (A-B plot) for 





























Fig. 1. a mDLSTM sensor. b Waveform example of the DLS measurement, illustrating the sphygmogram in an 
infant. c An example of the measured heart rate trend of ECG and DLS at the abdomen.
Table 1. Patient characteristics of all infants for each group at birth and at the time of measurement
Group 1 Group 2 p value
N 15 16
At birth
GA, weeks 28[6/7] (27[1/7]–31[5/7]) 30[4/7] (28[4/7]–31[5/7]) 0.44
Birth weight, g 1,190 (942–2,080) 1,330 (1,040–1,577.5) 0.92
SGA 5 (33.3) 8 (50.0) 0.57
Male gender 10 (66.7) 5 (31.2) 0.11
Cesarean section 8 (53.3) 12 (75.0) 0.38
APGAR score at 1 min 6 (5–8) 6.5 (3.75–8) 0.69
APGAR score at 5 min 8 (7–8.5) 8.5 (7–9) 0.40
Umbilical cord pH 7.31 (7.26–7.35) 7.29 (7.23–7.31) 0.22
Multiples 4 (26.7) 7 (43.8) 0.54
At the time of measurement
Time since birth, days 8 (6–18) 5 (3–15) 0.64
Weight, g 1,720 (1,160–1,930) 1,392 (1,164–1,628) 0.51
Admission survival 14 (93.3) 15 (93.8) >0.99
Ventilation 0.45
Noninvasive 13 (86.7) 11 (68.8)
None 2 (13.3) 5 (31.2)
Initial number of DLS-ECG data pairs 1,260 1,344
Values are expressed as median (IQR) or n (%), unless otherwise indicated. The Mann-Whitney U test for continuous variables and 
Fisher’s exact test for categorical variables were used to test significance with a two-sided p value <0.05. GA, gestational age; SGA, small 
for gestational age; DLS, dynamic light scattering; ECG, electrocardiogram.
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The optimal SNR was applied to the second dataset to deter-
mine agreement between DLS and ECG at every location. Agree-
ment between HR measured with both pulse oximetry and ECG 
was also analyzed. Incomplete data pairs were excluded from the 
analyses. Data pairs were excluded when non-DLS measurements 
failed. Data were analyzed in R v3.5.3 (The R Foundation for Sta-
tistical Computing, Vienna, Austria).
Results
A total of 34 infants were included between October 
2017 and August 2018. Three patients were excluded 
from the analyses: 1 case of data logging failure and 2 
cases with a postinclusion diagnosis of sepsis. Infants 
were randomly divided into 2 groups, with 15 infants in 
group 1 and 16 infants in group 2. There were no signifi-
cant differences in basic patient characteristics between 
the 2 groups at birth and at the time of measurement (Ta-
ble 1). Groups 1 and 2 consisted of 1,260 and 1,344 initial 
DLS and ECG HR data pairs per measurement site, re-
spectively, after which incomplete data pairs were re-
moved. At every measurement site, the mDLSTM sensor 
(Fig. 1a) was able to provide a signal in which character-
istics of an arterial blood flow waveform could be identi-
fied (Fig. 1b). The DLS HR measurements were able to 
follow the trend of ECG during rapid HR changes (Fig. 1c).
The discriminative ability of the DLS SNR varied 
greatly between measurement sites. The highest ROC 
AUC was 0.94 (n = 1,180, 95% CI 0.90–0.99) when DLS 
HR was measured at the forehead, with a sensitivity and 
specificity of 87 and 90%, respectively (Fig.  2). At this 
measurement site, the optimal cut-off value (J) for the 
DLS SNR was 1.66 (Table 2). Measurements performed 
Table 2. Agreement between heart rate measured with DLS and POX with ECG
DLS-ECG
SNR filter No Yes










Forehead –4.61 (–40.14 to 30.93) 1,310 –0.73 (–15.46 to 14.00) 1,066 1.66
Upper extremity –9.26 (–60.64 to 42.13) 1,322 –1.26 (–21.70 to 19.19) 1,009 2.25
Thorax –12.50 (–71.18 to 46.17) 1,307 –2.62 (–36.39 to 31.15) 788 4.29
Lower extremity –18.99 (–88.85 to 50.86) 1,312 –1.82 (–27.32 to 23.68) 693 3.63
Abdomen –37.55 (–116.34 to 41.25) 1,230 –16.25 (–78.73 to 46.23) 646 0.81
POX-ECG Data pairs upper/lower extremity, n
Standard of care POX 0.18 (–6.14 to 6.51) 6,476 414/6,062
Additional POX –0.06 (–5.23 to 5.36) 6,467 6,062/414
DLS, dynamic light scattering; ECG, electrocardiogram; POX, pulse oximetry; SNR, signal-to-noise ratio; LoA, limit of agreement; 
bpm, beats per minute.














Upper extremity: n = 1154, AUC = 0.91, 95% CI = 0.87–0.94
Forehead: n = 1180, AUC = 0.94, 95% CI = 0.90–0.99
Lower extremity: n = 1197, AUC = 0.91, 95% CI = 0.88–0.95 
Thorax: n = 1185, AUC = 0.86, 95% CI = 0.79–0.93
Abdomen: n = 1191, AUC = 0.87, 95% CI = 0.78–0.95
Fig. 2. Receiver operating characteristic curves for detection of 
DLS heart rate signal using the DLS signal-to-noise ratio with the 
mDLSTM sensor at all measurement sites. Number of data pairs (n) 
after exclusion of incomplete data pairs (initially n = 1,260), area 
under the curve (AUC) with the 95% CI are presented.
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Fig. 3. Agreement (A-B plot) between heart 
rate measurements obtained with the 
mDLSTM sensor and ECG, plotted for every 
measured DLS SNR value at the forehead 
(a), an upper extremity (b), the thorax (c), 
a lower extremity (d), and the abdomen 
(e). Agreement is presented as bias with 
upper and lower limits of agreement (dark 
grey). The percentage of remaining data 
pairs (DLS-ECG) used for the Bland-Alt-




at the thorax and abdomen had the lowest AUC (Fig. 2). 
Moreover, respiratory motion created waveforms that 
were detected as heartbeats, resulting in high DLS SNR 
values at incorrectly measured DLS HR values. The 
Bland-Altman analysis performed for every DLS SNR 
value showed improvement of the agreement between 
DLS and ECG as the SNR increased, together with an ex-
treme decrease in the remaining data pairs (DLS-ECG; 
Fig. 3).
After application of the SNR cut-off value in the sec-
ond group, agreement between HR measured with DLS 
and ECG improved significantly for each site (Table 2). 
When HR measurements were obtained at the forehead, 
agreement (bias [lower LoA – upper LoA]) improved 
from –4.61 (–40.14 to 30.93) to –0.73 (–15.46 to 14.00) 
bpm (Fig.  4) while retaining approximately 81% (i.e., 
1,066/1,310) of all data pairs (Table 2). HR measured with 
the POX-S and POX-A during this period showed a bias 
(lower LoA – upper LoA) of 0.1 (–3.8 to 3.9) bpm in both 
when compared with ECG HR measurements (Fig.  4). 
Agreement at other sites also improved markedly, but the 
LoAs remained wide even after exclusion of approxi-
mately half of all the included data pairs (Table 2). The 
overall agreement between HR measured with the 2 pulse 
oximeters and ECG was comparable to or better than in 
previous studies (Table 2) [19–21].
Discussion
This study is the first to evaluate the performance of a 
miniaturized DLS sensor for HR monitoring, showing 
good agreement with ECG-derived HR when not distort-
ed by movement. DLS technology has several potential 
advantages over current neonatal HR monitoring. Sen-
sors with this technology can be smaller than any current 
HR sensor, and also have the potential for measuring oth-
er hemodynamic parameters such as blood flow. The key 
strength of DLS is, however, the excellent signal strength 
due to the exclusive detection of hemoglobin motion, 
provided that breathing and movement artifacts can be 
adequately filtered out. 
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mean (-0.7 bpm)
-2 SD (-15.5 bpm)
+2 SD (3.9 bpm)
mean (0.1 bpm)
-2 SD (-3.8 bpm)
+2 SD (3.9 bpm)
mean (0.1 bpm)























































































Average heart rate, bpm
100 120 140 160 180 200
Average heart rate, bpm
100 120 140 160 180 200




Fig. 4. Bland-Altman plots (A-B plot) of the heart rate (HR) differ-
ence against the average HR during measurements performed at 
the forehead. a Agreement between DLS and ECG HR of data pairs 
with a DLS SNR above the calculated cut-off value (1.66). b Agree-
ment between the standard of care POX (POX-S) and ECG HR. 
c Agreement between the additional POX (POX-A) and ECG HR.




Accurate detection of HR depends on both a good sig-
nal quality and the adequate filtering of artifacts. Move-
ment patterns in infants are particularly difficult to filter 
out compared to in adults. Movements of the extremities 
are abrupt, unpredictable, and of short duration, leading 
to a loss of HR detection. In addition, accuracy was 
strongly impaired when measuring at the thorax and ab-
domen due to respiration. Distortion of the DLS signal 
resulted in the registration of incorrect frequencies, am-
plitudes, and breathing-induced fluctuations (baseline 
wander), erroneously detecting the respiratory wave-
forms as heartbeats. As a consequence, falsely low HRs 
were measured with a high SNR and were therefore con-
sidered to be good-quality measurements. The most im-
portant resolution to this problem involves band-pass fil-
tering of HRs specific to the neonatal population. In ad-
dition, the narrow light beam creates a small measurement 
site, amplifying the influence of movement and requiring 
good skin adhesion. The convex sensor surface, in com-
bination with the applied skin adhesive, allowed rotation-
al movement relative to the skin, influencing the accuracy 
of the measurements. This can potentially be resolved by 
a flat sensor surface. For clinical practice, the substantial 
loss of data due to signal distortion is the largest concern, 
resulting in the absence of HR measurements during an 
unacceptable portion of the measurement time.
Despite the main limitation of this study, the small size 
of the mDLSTM sensor and its noninvasiveness demon-
strated excellent usability. However, regular signal failure 
currently provides insufficient HR information for a 
comparison of clinical use to ECG. Furthermore, the per-
formance in extremely premature infants and during cir-
culatory deterioration could not be derived from the find-
ings in the stable patients in this study. Future studies 
should investigate the use of the DLS technology during 
more dynamic settings, such as resuscitation. The setup 
of this study analysis did not evaluate accuracy during 
bradycardia, which is of particular importance for in-
fants. Although the DLS class I laser should be safe for the 
retina, this has not been proven in premature infants. In 
addition, the blink reflex is often absent in infants, allow-
ing for longer exposure. Until its safety is proven, its clin-
ical use requires the implementation of a laser power 
down when detached from the skin.
With the exception of the DLS signal, the output of all 
clinical devices (for ECG and pulse oximetry) is a HR 
which is averaged over several seconds. Although DLS 
measurements adequately followed the general HR trend, 
the absence of averaging might explain the earlier detec-
tion of changes in HR when compared to the ECG-de-
rived HR. Agreement between the pulse oximeters and 
ECG was better than that described in the literature so far 
[19–21]. This might be explained by the use of precisely 
time-synchronized computers. Furthermore, analyses 
were corrected for repeated measures, resulting in an in-
crease of the SD. When applying the demands for accu-
racy for clinical use on DLS HR measurements, the dif-
ficulty lies within the application of the norms for clinical 
HR detection, which are aimed at ECG accuracy and reli-
ability [15]. Although accuracy could be determined as a 
deviation from the reference value, the norms do not 
specify the percentage of time in which the HR should be 
accurately detected. With the necessary improvements, 
future iterations of DLS technology will be able to provide 
specific advantages over currently used techniques like 
ECG and pulse oximetry, because of the possibility of 
measuring HR, blood flow, and cardiac output with a sin-
gle sensor, and even contact-free up to a distance of sev-
eral millimeters from the skin. Skin pigmentation is un-
likely to affect the detection of hemoglobin motion as 
DLS depends on the scattering of light instead of light 
absorption.
As previous studies reported, DLS has the potential to 
measure various hemodynamic parameters [14]. Blood 
flow and cardiac output are currently unavailable param-
eters in neonatal intensive care but can be valuable for the 
assessment of infants due to infant physiology. As DLS 
has the potential to measure blood flow in patients of all 
ages, more research is required to investigate DLS blood 
flow measurements. Novel applications in the neonatal 
population could include the early detection of hypoten-
sion, the detection of microcirculatory impairment, or 
the replacement of functional echocardiography. The ab-
sence of an available clinical gold standard for flow mea-
surement, however, complicates the investigation of the 
DLS technology for flow measurements in future studies. 
Conclusion
DLS is a new and promising miniaturized technique 
for noninvasive HR detection in infants, showing good 
agreement with ECG-derived HR when measured at the 
forehead under a stable condition of the infant. Move-
ment, however, has a notable influence on accuracy. 
Overall, the accuracy of HR detection with DLS is cur-
rently inferior to ECG and pulse oximetry. In addition, 
DLS has the potential for continuously measuring other 
hemodynamic parameters such as blood flow, an impor-




We would like to thank all patients and parents for their par-
ticipation. We also would like to thank the nurses, medical staff, 
and Ms. K.A.L. Mauff for her advice on the statistical section.
Statement of Ethics
This prospective observational cohort study was approved by 
the Medical Ethics Committee of Erasmus Medical Center (MEC-
2017-059). Parental consent was provided both verbally and writ-
ten before inclusion in the study.
Disclosure Statement
The authors have no conflicts of interest to declare.
Funding Sources
The mDLSTM sensor was kindly provided by Elfi-Tech Ltd. The 
study did not receive any funds.
Author Contributions
N.H.G.-P. enrolled patients and performed the mDLS mea-
surements, conducted data analyses, and had the lead in manu-
script writing. T.E. supported patient enrolment and participated 
in data analyses. T.G.G. contributed to technical documentation 
and the study setup. R.C.J.J. participated in the study setup. 
I.K.M.R. initiated the study and provided clinical input through-
out the study. W.W. performed the study and analyses design, eth-
ics board submission, technical documentation, and manuscript 
writing.
References
 1 Zhao J, Gonzalez F, Mu D. Apnea of prema-
turity: from cause to treatment. Eur J Pediatr. 
2011 Sep; 170(9): 1097–105.
 2 Martin RJ, Wang K, Köroğlu O, Di Fiore J, Kc 
P. Intermittent hypoxic episodes in preterm 
infants: do they matter? Neonatology. 2011; 
100(3): 303–10.
 3 Sharma A, Ford S, Calvert J. Adaptation for 
life: a review of neonatal physiology. Anaes-
thesia Intensive Care Med. 2011; 12(3):P85–
90.
 4 Odman S, Oberg PA. Movement-induced po-
tentials in surface electrodes. Med Biol Eng 
Comput. 1982 Mar; 20(2): 159–66.
 5 Malloy-McDonald MB. Skin care for high-
risk neonates. J Wound Ostomy Continence 
Nurs. 1995 Jul; 22(4): 177–82.
 6 Eichenfield LF, Hardaway CA. Neonatal der-
matology. Curr Opin Pediatr. 1999 Oct; 11(5): 
471–4.
 7 Hay WW Jr, Rodden DJ, Collins SM, Melara 
DL, Hale KA, Fashaw LM. Reliability of con-
ventional and new pulse oximetry in neonatal 
patients. J Perinatol. 2002 Jul-Aug; 22(5): 360–
6.
 8 Murray JS, Noonan C, Quigley S, Curley MA. 
Medical device-related hospital-acquired 
pressure ulcers in children: an integrative re-
view. J Pediatr Nurs. 2013 Nov-Dec; 28(6): 
585–95.
 9 Myerburg RJ, Halperin H, Egan DA, Boineau 
R, Chugh SS, Gillis AM, et al. Pulseless electric 
activity: definition, causes, mechanisms, 
management, and research priorities for the 
next decade: report from a National Heart, 
Lung, and Blood Institute workshop. Circula-
tion. 2013 Dec; 128(23): 2532–41.
10 Anton O, Fernandez R, Rendon-Morales E, 
Aviles-Espinosa R, Jordan H, Rabe H. Heart 
Rate Monitoring in Newborn Babies: A Sys-
tematic Review. Neonatology. 2019; 116(3): 
199–210.
11 Kuznik BI, Fine IW, Kaminsky AV. A nonin-
vasive method of examination of the hemo-
stasis system. Bull Exp Biol Med. 2011 Sep; 
151(5): 655–7.
12 Lerman Y, Werber MM, Fine I, Kemelman P. 
Preliminary clinical evaluation of a noninva-
sive device for the measurement of coagula-
bility in the elderly. J Blood Med. 2011; 2: 113–
8.
13 Fine I, Kuznik BI, Kaminsky AV, Shenkman 
L, Kustovsjya EM, Maximova OG. New non-
invasive index for evaluation of the vascular 
age of healthy and sick people. J Biomed Opt. 
2012 Aug; 17(8): 087002–1.
14 Wu Z, Boersema GS, Taha D, Fine I, Menon 
A, Kleinrensink GJ, et al. Postoperative He-
modynamic Index Measurement with Minia-
turized Dynamic Light Scattering Predicts 
Colorectal Anastomotic Healing. Surg Innov. 
2016 Apr; 23(2): 115–23.
15 Commission IE. Medical electrical equipment 
- Part 2-27 Particular requirements for the ba-
sic safety and essential performance of elec-
trocardiographic monitoring equipment 
(IEC 60601-2-27: 2011, IDT; IEC 60601-2-27: 
2011/C1: 2012, IDT). 2014. pp. 39–40.
16 Obuchowski NA. Nonparametric analysis of 
clustered ROC curve data. Biometrics. 1997 
Jun; 53(2): 567–78.
17 Youden WJ. Index for rating diagnostic tests. 
Cancer. 1950 Jan; 3(1): 32–5.
18 Bland JM, Altman DG. Agreement between 
methods of measurement with multiple ob-
servations per individual. J Biopharm Stat. 
2007; 17(4): 571–82.
19 Kamlin CO, Dawson JA, O’Donnell CP, Mor-
ley CJ, Donath SM, Sekhon J, et al. Accuracy 
of pulse oximetry measurement of heart rate 
of newborn infants in the delivery room. J Pe-
diatr. 2008 Jun; 152(6): 756–60.
20 Singh JK, Kamlin CO, Morley CJ, O’Donnell 
CP, Donath SM, Davis PG. Accuracy of pulse 
oximetry in assessing heart rate of infants in 
the neonatal intensive care unit. J Paediatr 
Child Health. 2008 May; 44(5): 273–5.
21 van Vonderen JJ, Hooper SB, Kroese JK, Ro-
est AA, Narayen IC, van Zwet EW, et al. Pulse 
oximetry measures a lower heart rate at birth 
compared with electrocardiography. J Pedi-
atr. 2015 Jan; 166(1): 49–53.
